Oct 21, 2026 04:01PM
Aug 5, 2026 07:22AM
Aug 5, 2026 07:00AM
Jul 22, 2026 07:00AM
Jul 15, 2026 07:01AM
Jul 15, 2026 07:00AM
Jun 29, 2026 07:00AM BioCryst to close Birmingham lab and shift to external R&D model
Jun 29, 2026 07:00AM
May 6, 2026 07:05AM
May 6, 2026 07:00AM
May 4, 2026 07:01AM
May 4, 2026 07:00AM
Apr 15, 2026 07:00AM
Apr 6, 2026 07:00AM BioCryst names Sandeep Menon as chief research and development officer
Apr 6, 2026 07:00AM
Feb 26, 2026 07:58AM
Feb 26, 2026 07:00AM
Feb 5, 2026 07:01AM
Jan 23, 2026 09:00AM
Jan 23, 2026 09:00AM
Jan 12, 2026 07:04AM BioCryst reports 2025 ORLADEYO revenue of $601 million, up 37%
Jan 12, 2026 07:00AM
Nov 16, 2025 03:00PM
Nov 12, 2025 08:00AM
Nov 4, 2025 09:12AM
Nov 3, 2025 07:03AM
Nov 3, 2025 07:00AM
Oct 20, 2025 07:00AM BioCryst to Report Third Quarter 2025 Financial Results on November 3
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM
Sep 11, 2025 08:59AM
Aug 4, 2025 07:01AM
Aug 4, 2025 07:00AM
Jul 31, 2025 07:00AM
Jul 31, 2025 07:00AM BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December
Jul 24, 2025 12:20PM
Jul 21, 2025 07:00AM
Jul 7, 2025 07:01AM
Jul 7, 2025 07:00AM
May 5, 2025 07:02AM
May 5, 2025 07:00AM
May 1, 2025 07:02AM BioCryst Pharma (BCRX) Appoints Steve Frank to its Board
May 1, 2025 07:00AM
Apr 21, 2025 07:00AM
Apr 12, 2025 04:00AM
Feb 24, 2025 07:29AM
Feb 24, 2025 07:00AM
Feb 10, 2025 07:00AM
Jan 10, 2025 07:01AM BioCryst Pharma (BCRX) Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437
Jan 10, 2025 07:00AM

1,233,469 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All